PositiveID Chairman and CEO William J. Caragol, called into SmallCapVoice.com to go over the business model and market for the Company’s exciting product lines.  PositiveID Corporation (OTCBB: PSID) develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.

For more information on iglucose, please visit http://www.iglucose.com. For sales and partnership opportunities, please contact Mary Ellen Harrison at 561-805-8028 ormeharrison@positiveidcorp.com.